Clinical trial
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young…
NCT00139113 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00139113 |
|---|---|
| Title | Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children |
| Official title | Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Alaska Native Medical Center GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis A |
| Intervention type | Biological |
| Interventions | hepatitis A vaccine |
| Enrollment | 248 |
| Start date | Sep 1, 1996 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | Aug 31, 2005 |
| Last update posted | Aug 20, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: